Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of the UK National Screening Committee’s draft recommendation on prostate cancer screening on future demand for PSMA PET-CT imaging, including modelling of the different demand scenarios included in the current public consultation.

The independent UK National Screening Committee (UK NSC), which is made up of leading medical and screening experts, advises ministers in all four nations of the United Kingdom on the evidence on screening. They have carried out an evidence review to look at screening for prostate cancer.  Where the committee is confident that screening provides more good than harm, they recommend a screening programme.  Treatment can lead to immediate life changing side effects which need to be balanced against potential benefits some years in the future.

On 28 November 2025, the UK NSC opened a 12-week public consultation on an evidence review to look at screening for prostate cancer and a draft recommendation to:

• offer a targeted national prostate cancer screening programme to men with confirmed BRCA1/2 gene variants every two years, from the age 45 years old to age 61 years old;
• not recommend population screening;
• not recommend targeted screening of black men;
• not recommend targeted screening of men with family history; and
• collaborate with the Transform trial team to answer outstanding questions on screening effectiveness for black men and men with a family history, as soon as trial data becomes available, and await the results of the study to develop and trial a more accurate test than the prostate specific antigen test alone, to improve the balance of the benefits and harms of screening.

Alongside the consultation, work is being carried out to assess the costs and resources required to deliver the possible screening pathway, this could include an assessment of future demand for PSMA PET-CT imaging.

We anticipate that the UK NSC will make a final recommendation on screening for prostate cancer in early 2026. My Rt Hon. Friend, the Secretary of State for Health and Social Care, will consider this and make a decision on whether to accept and next steps at this point.